Nuzenio

Ceo Biopharma Dive

Ceo Biopharma Dive entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 19:14:51 GMTWith $263M, LifeMine unearths a new drug for organ transplants - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 13:40:35 GMTCardiac drug developer Braveheart banks more than $382M in IPO - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 03:18:37 GMTJ&J pharma leader to retire; Krystal slumps on gene therapy miss - BioPharma DiveBioPharma Dive · Tue, 04 Aug 2026 14:35:26 GMTMapLight CEO on what investors missed in the biotech’s schizophrenia data - BioPharma DiveBioPharma Dive · Wed, 29 Jul 2026 07:00:00 GMTCaldera, Vidya add to recent flurry of biotech mergers - BioPharma DiveBioPharma Dive · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 19:14:51 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive
Thu, 06 Aug 2026 13:40:35 GMTWith $263M, LifeMine unearths a new drug for organ transplants - BioPharma Dive
Thu, 06 Aug 2026 03:18:37 GMTCardiac drug developer Braveheart banks more than $382M in IPO - BioPharma Dive
Tue, 04 Aug 2026 14:35:26 GMTJ&J pharma leader to retire; Krystal slumps on gene therapy miss - BioPharma Dive
Wed, 29 Jul 2026 07:00:00 GMTMapLight CEO on what investors missed in the biotech’s schizophrenia data - BioPharma Dive
Wed, 29 Jul 2026 07:00:00 GMTCaldera, Vidya add to recent flurry of biotech mergers - BioPharma Dive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ceo Biopharma Dive.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.